世界のバイオシミラー/フォローオンバイオロジクス市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Biosimilars/follow-on-biologics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0847 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、バイオシミラー/フォローオンバイオロジクスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子、その他）、用途別市場規模（血液疾患、腫瘍学疾患、慢性・自己免疫疾患、成長ホルモン欠乏症、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・バイオシミラー/フォローオンバイオロジクスの市場動向 ・企業の競争状況、市場シェア ・バイオシミラー/フォローオンバイオロジクスの種類別市場規模（ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子、その他） ・バイオシミラー/フォローオンバイオロジクスの用途別市場規模（血液疾患、腫瘍学疾患、慢性・自己免疫疾患、成長ホルモン欠乏症、その他） ・バイオシミラー/フォローオンバイオロジクスの北米市場規模2016-2027（アメリカ、カナダ） ・バイオシミラー/フォローオンバイオロジクスのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・バイオシミラー/フォローオンバイオロジクスのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・バイオシミラー/フォローオンバイオロジクスの中南米市場規模2016-2027（メキシコ、ブラジル） ・バイオシミラー/フォローオンバイオロジクスの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis (Sandoz)、Synthon Pharmaceuticals、Teva Pharmaceutical Industries、LG Life Sciences、Celltrion Biocon、Hospira、Merck Serono (Merck)、Biogen idec、Genentech (Roche)） ・結論

Biosimilars or follow-on-biologics are the “copied” and licensed versions of those reference biologics that have undergone patent expiration. Biosimilars development and validation with reference biologics is a crucial aspect of the overall development process. 

Market Analysis and Insights: Global Biosimilars/follow-on-biologics Market
The global Biosimilars/follow-on-biologics market size is projected to reach US$ 11500 million by 2026, from US$ 9291.3 million in 2019, at a CAGR of 3.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biosimilars/follow-on-biologics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biosimilars/follow-on-biologics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biosimilars/follow-on-biologics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biosimilars/follow-on-biologics market.

Global Biosimilars/follow-on-biologics Scope and Market Size
Biosimilars/follow-on-biologics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilars/follow-on-biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others

Segment by Application
Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis (Sandoz)
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck Serono (Merck)
Biogen idec
Genentech (Roche)

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilars/follow-on-biologics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Human growth hormone
1.2.3 Erythropoietin
1.2.4 Monoclonal antibodies
1.2.5 Insulin
1.2.6 Interferon
1.2.7 Granulocyte-Colony Stimulating Factor
1.2.8 Others
1.3 Market by Application
1.3.1 Global Biosimilars/follow-on-biologics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Blood disorders
1.3.3 Oncology diseases
1.3.4 Chronic and autoimmune diseases
1.3.5 Growth hormone deficiencies
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Biosimilars/follow-on-biologics Market Perspective (2016-2027)
2.2 Biosimilars/follow-on-biologics Growth Trends by Regions
2.2.1 Biosimilars/follow-on-biologics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biosimilars/follow-on-biologics Historic Market Share by Regions (2016-2021)
2.2.3 Biosimilars/follow-on-biologics Forecasted Market Size by Regions (2022-2027)
2.3 Biosimilars/follow-on-biologics Industry Dynamic
2.3.1 Biosimilars/follow-on-biologics Market Trends
2.3.2 Biosimilars/follow-on-biologics Market Drivers
2.3.3 Biosimilars/follow-on-biologics Market Challenges
2.3.4 Biosimilars/follow-on-biologics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Biosimilars/follow-on-biologics Players by Revenue
3.1.1 Global Top Biosimilars/follow-on-biologics Players by Revenue (2016-2021)
3.1.2 Global Biosimilars/follow-on-biologics Revenue Market Share by Players (2016-2021)
3.2 Global Biosimilars/follow-on-biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biosimilars/follow-on-biologics Revenue
3.4 Global Biosimilars/follow-on-biologics Market Concentration Ratio
3.4.1 Global Biosimilars/follow-on-biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilars/follow-on-biologics Revenue in 2020
3.5 Biosimilars/follow-on-biologics Key Players Head office and Area Served
3.6 Key Players Biosimilars/follow-on-biologics Product Solution and Service
3.7 Date of Enter into Biosimilars/follow-on-biologics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Biosimilars/follow-on-biologics Breakdown Data by Type
4.1 Global Biosimilars/follow-on-biologics Historic Market Size by Type (2016-2021)
4.2 Global Biosimilars/follow-on-biologics Forecasted Market Size by Type (2022-2027)

5 Biosimilars/follow-on-biologics Breakdown Data by Application
5.1 Global Biosimilars/follow-on-biologics Historic Market Size by Application (2016-2021)
5.2 Global Biosimilars/follow-on-biologics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Biosimilars/follow-on-biologics Market Size (2016-2027)
6.2 North America Biosimilars/follow-on-biologics Market Size by Type
6.2.1 North America Biosimilars/follow-on-biologics Market Size by Type (2016-2021)
6.2.2 North America Biosimilars/follow-on-biologics Market Size by Type (2022-2027)
6.2.3 North America Biosimilars/follow-on-biologics Market Size by Type (2016-2027)
6.3 North America Biosimilars/follow-on-biologics Market Size by Application
6.3.1 North America Biosimilars/follow-on-biologics Market Size by Application (2016-2021)
6.3.2 North America Biosimilars/follow-on-biologics Market Size by Application (2022-2027)
6.3.3 North America Biosimilars/follow-on-biologics Market Size by Application (2016-2027)
6.4 North America Biosimilars/follow-on-biologics Market Size by Country
6.4.1 North America Biosimilars/follow-on-biologics Market Size by Country (2016-2021)
6.4.2 North America Biosimilars/follow-on-biologics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Biosimilars/follow-on-biologics Market Size (2016-2027)
7.2 Europe Biosimilars/follow-on-biologics Market Size by Type
7.2.1 Europe Biosimilars/follow-on-biologics Market Size by Type (2016-2021)
7.2.2 Europe Biosimilars/follow-on-biologics Market Size by Type (2022-2027)
7.2.3 Europe Biosimilars/follow-on-biologics Market Size by Type (2016-2027)
7.3 Europe Biosimilars/follow-on-biologics Market Size by Application
7.3.1 Europe Biosimilars/follow-on-biologics Market Size by Application (2016-2021)
7.3.2 Europe Biosimilars/follow-on-biologics Market Size by Application (2022-2027)
7.3.3 Europe Biosimilars/follow-on-biologics Market Size by Application (2016-2027)
7.4 Europe Biosimilars/follow-on-biologics Market Size by Country
7.4.1 Europe Biosimilars/follow-on-biologics Market Size by Country (2016-2021)
7.4.2 Europe Biosimilars/follow-on-biologics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Biosimilars/follow-on-biologics Market Size (2016-2027)
8.2 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Type
8.2.1 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Type (2016-2027)
8.3 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Application
8.3.1 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Application (2016-2027)
8.4 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Region
8.4.1 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Biosimilars/follow-on-biologics Market Size (2016-2027)
9.2 Latin America Biosimilars/follow-on-biologics Market Size by Type
9.2.1 Latin America Biosimilars/follow-on-biologics Market Size by Type (2016-2021)
9.2.2 Latin America Biosimilars/follow-on-biologics Market Size by Type (2022-2027)
9.2.3 Latin America Biosimilars/follow-on-biologics Market Size by Type (2016-2027)
9.3 Latin America Biosimilars/follow-on-biologics Market Size by Application
9.3.1 Latin America Biosimilars/follow-on-biologics Market Size by Application (2016-2021)
9.3.2 Latin America Biosimilars/follow-on-biologics Market Size by Application (2022-2027)
9.3.3 Latin America Biosimilars/follow-on-biologics Market Size by Application (2016-2027)
9.4 Latin America Biosimilars/follow-on-biologics Market Size by Country
9.4.1 Latin America Biosimilars/follow-on-biologics Market Size by Country (2016-2021)
9.4.2 Latin America Biosimilars/follow-on-biologics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Biosimilars/follow-on-biologics Market Size (2016-2027)
10.2 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type
10.2.1 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type (2016-2027)
10.3 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application
10.3.1 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application (2016-2027)
10.4 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Country
10.4.1 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis (Sandoz)
11.1.1 Novartis (Sandoz) Company Details
11.1.2 Novartis (Sandoz) Business Overview
11.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Introduction
11.1.4 Novartis (Sandoz) Revenue in Biosimilars/follow-on-biologics Business (2016-2021)
11.1.5 Novartis (Sandoz) Recent Development
11.2 Synthon Pharmaceuticals
11.2.1 Synthon Pharmaceuticals Company Details
11.2.2 Synthon Pharmaceuticals Business Overview
11.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Introduction
11.2.4 Synthon Pharmaceuticals Revenue in Biosimilars/follow-on-biologics Business (2016-2021)
11.2.5 Synthon Pharmaceuticals Recent Development
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Details
11.3.2 Teva Pharmaceutical Industries Business Overview
11.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Introduction
11.3.4 Teva Pharmaceutical Industries Revenue in Biosimilars/follow-on-biologics Business (2016-2021)
11.3.5 Teva Pharmaceutical Industries Recent Development
11.4 LG Life Sciences
11.4.1 LG Life Sciences Company Details
11.4.2 LG Life Sciences Business Overview
11.4.3 LG Life Sciences Biosimilars/follow-on-biologics Introduction
11.4.4 LG Life Sciences Revenue in Biosimilars/follow-on-biologics Business (2016-2021)
11.4.5 LG Life Sciences Recent Development
11.5 Celltrion Biocon
11.5.1 Celltrion Biocon Company Details
11.5.2 Celltrion Biocon Business Overview
11.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Introduction
11.5.4 Celltrion Biocon Revenue in Biosimilars/follow-on-biologics Business (2016-2021)
11.5.5 Celltrion Biocon Recent Development
11.6 Hospira
11.6.1 Hospira Company Details
11.6.2 Hospira Business Overview
11.6.3 Hospira Biosimilars/follow-on-biologics Introduction
11.6.4 Hospira Revenue in Biosimilars/follow-on-biologics Business (2016-2021)
11.6.5 Hospira Recent Development
11.7 Merck Serono (Merck)
11.7.1 Merck Serono (Merck) Company Details
11.7.2 Merck Serono (Merck) Business Overview
11.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Introduction
11.7.4 Merck Serono (Merck) Revenue in Biosimilars/follow-on-biologics Business (2016-2021)
11.7.5 Merck Serono (Merck) Recent Development
11.8 Biogen idec
11.8.1 Biogen idec Company Details
11.8.2 Biogen idec Business Overview
11.8.3 Biogen idec Biosimilars/follow-on-biologics Introduction
11.8.4 Biogen idec Revenue in Biosimilars/follow-on-biologics Business (2016-2021)
11.8.5 Biogen idec Recent Development
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Details
11.9.2 Genentech (Roche) Business Overview
11.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Introduction
11.9.4 Genentech (Roche) Revenue in Biosimilars/follow-on-biologics Business (2016-2021)
11.9.5 Genentech (Roche) Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Biosimilars/follow-on-biologics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Human growth hormone
Table 3. Key Players of Erythropoietin
Table 4. Key Players of Monoclonal antibodies
Table 5. Key Players of Insulin
Table 6. Key Players of Interferon
Table 7. Key Players of Granulocyte-Colony Stimulating Factor
Table 8. Key Players of Others
Table 9. Global Biosimilars/follow-on-biologics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Biosimilars/follow-on-biologics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Biosimilars/follow-on-biologics Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Biosimilars/follow-on-biologics Market Share by Regions (2016-2021)
Table 13. Global Biosimilars/follow-on-biologics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Biosimilars/follow-on-biologics Market Share by Regions (2022-2027)
Table 15. Biosimilars/follow-on-biologics Market Trends
Table 16. Biosimilars/follow-on-biologics Market Drivers
Table 17. Biosimilars/follow-on-biologics Market Challenges
Table 18. Biosimilars/follow-on-biologics Market Restraints
Table 19. Global Biosimilars/follow-on-biologics Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Biosimilars/follow-on-biologics Market Share by Players (2016-2021)
Table 21. Global Top Biosimilars/follow-on-biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars/follow-on-biologics as of 2020)
Table 22. Ranking of Global Top Biosimilars/follow-on-biologics Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Biosimilars/follow-on-biologics Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Biosimilars/follow-on-biologics Product Solution and Service
Table 26. Date of Enter into Biosimilars/follow-on-biologics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Biosimilars/follow-on-biologics Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Biosimilars/follow-on-biologics Revenue Market Share by Type (2016-2021)
Table 30. Global Biosimilars/follow-on-biologics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Biosimilars/follow-on-biologics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Biosimilars/follow-on-biologics Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Biosimilars/follow-on-biologics Revenue Market Share by Application (2016-2021)
Table 34. Global Biosimilars/follow-on-biologics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Biosimilars/follow-on-biologics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Biosimilars/follow-on-biologics Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Biosimilars/follow-on-biologics Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Biosimilars/follow-on-biologics Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Biosimilars/follow-on-biologics Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Biosimilars/follow-on-biologics Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Biosimilars/follow-on-biologics Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Biosimilars/follow-on-biologics Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Biosimilars/follow-on-biologics Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Biosimilars/follow-on-biologics Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Biosimilars/follow-on-biologics Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Biosimilars/follow-on-biologics Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Biosimilars/follow-on-biologics Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Biosimilars/follow-on-biologics Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Biosimilars/follow-on-biologics Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Biosimilars/follow-on-biologics Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Biosimilars/follow-on-biologics Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Biosimilars/follow-on-biologics Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Biosimilars/follow-on-biologics Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Biosimilars/follow-on-biologics Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Biosimilars/follow-on-biologics Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Biosimilars/follow-on-biologics Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Biosimilars/follow-on-biologics Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Biosimilars/follow-on-biologics Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Biosimilars/follow-on-biologics Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Biosimilars/follow-on-biologics Market Size by Country (2022-2027) & (US$ Million)
Table 66. Novartis (Sandoz) Company Details
Table 67. Novartis (Sandoz) Business Overview
Table 68. Novartis (Sandoz) Biosimilars/follow-on-biologics Product
Table 69. Novartis (Sandoz) Revenue in Biosimilars/follow-on-biologics Business (2016-2021) & (US$ Million)
Table 70. Novartis (Sandoz) Recent Development
Table 71. Synthon Pharmaceuticals Company Details
Table 72. Synthon Pharmaceuticals Business Overview
Table 73. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product
Table 74. Synthon Pharmaceuticals Revenue in Biosimilars/follow-on-biologics Business (2016-2021) & (US$ Million)
Table 75. Synthon Pharmaceuticals Recent Development
Table 76. Teva Pharmaceutical Industries Company Details
Table 77. Teva Pharmaceutical Industries Business Overview
Table 78. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product
Table 79. Teva Pharmaceutical Industries Revenue in Biosimilars/follow-on-biologics Business (2016-2021) & (US$ Million)
Table 80. Teva Pharmaceutical Industries Recent Development
Table 81. LG Life Sciences Company Details
Table 82. LG Life Sciences Business Overview
Table 83. LG Life Sciences Biosimilars/follow-on-biologics Product
Table 84. LG Life Sciences Revenue in Biosimilars/follow-on-biologics Business (2016-2021) & (US$ Million)
Table 85. LG Life Sciences Recent Development
Table 86. Celltrion Biocon Company Details
Table 87. Celltrion Biocon Business Overview
Table 88. Celltrion Biocon Biosimilars/follow-on-biologics Product
Table 89. Celltrion Biocon Revenue in Biosimilars/follow-on-biologics Business (2016-2021) & (US$ Million)
Table 90. Celltrion Biocon Recent Development
Table 91. Hospira Company Details
Table 92. Hospira Business Overview
Table 93. Hospira Biosimilars/follow-on-biologics Product
Table 94. Hospira Revenue in Biosimilars/follow-on-biologics Business (2016-2021) & (US$ Million)
Table 95. Hospira Recent Development
Table 96. Merck Serono (Merck) Company Details
Table 97. Merck Serono (Merck) Business Overview
Table 98. Merck Serono (Merck) Biosimilars/follow-on-biologics Product
Table 99. Merck Serono (Merck) Revenue in Biosimilars/follow-on-biologics Business (2016-2021) & (US$ Million)
Table 100. Merck Serono (Merck) Recent Development
Table 101. Biogen idec Company Details
Table 102. Biogen idec Business Overview
Table 103. Biogen idec Revenue in Biosimilars/follow-on-biologics Business (2016-2021) & (US$ Million)
Table 104. Biogen idec Recent Development
Table 105. Genentech (Roche) Company Details
Table 106. Genentech (Roche) Business Overview
Table 107. Genentech (Roche) Biosimilars/follow-on-biologics Product
Table 108. Genentech (Roche) Revenue in Biosimilars/follow-on-biologics Business (2016-2021) & (US$ Million)
Table 109. Genentech (Roche) Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosimilars/follow-on-biologics Market Share by Type: 2020 VS 2027
Figure 2. Human growth hormone Features
Figure 3. Erythropoietin Features
Figure 4. Monoclonal antibodies Features
Figure 5. Insulin Features
Figure 6. Interferon Features
Figure 7. Granulocyte-Colony Stimulating Factor Features
Figure 8. Others Features
Figure 9. Global Biosimilars/follow-on-biologics Market Share by Application: 2020 VS 2027
Figure 10. Blood disorders Case Studies
Figure 11. Oncology diseases Case Studies
Figure 12. Chronic and autoimmune diseases Case Studies
Figure 13. Growth hormone deficiencies Case Studies
Figure 14. Others Case Studies
Figure 15. Biosimilars/follow-on-biologics Report Years Considered
Figure 16. Global Biosimilars/follow-on-biologics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Biosimilars/follow-on-biologics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Biosimilars/follow-on-biologics Market Share by Regions: 2020 VS 2027
Figure 19. Global Biosimilars/follow-on-biologics Market Share by Regions (2022-2027)
Figure 20. Global Biosimilars/follow-on-biologics Market Share by Players in 2020
Figure 21. Global Top Biosimilars/follow-on-biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars/follow-on-biologics as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Biosimilars/follow-on-biologics Revenue in 2020
Figure 23. Global Biosimilars/follow-on-biologics Revenue Market Share by Type (2016-2021)
Figure 24. Global Biosimilars/follow-on-biologics Revenue Market Share by Type (2022-2027)
Figure 25. North America Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Biosimilars/follow-on-biologics Market Share by Type (2016-2027)
Figure 27. North America Biosimilars/follow-on-biologics Market Share by Application (2016-2027)
Figure 28. North America Biosimilars/follow-on-biologics Market Share by Country (2016-2027)
Figure 29. United States Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Biosimilars/follow-on-biologics Market Share by Type (2016-2027)
Figure 33. Europe Biosimilars/follow-on-biologics Market Share by Application (2016-2027)
Figure 34. Europe Biosimilars/follow-on-biologics Market Share by Country (2016-2027)
Figure 35. Germany Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Biosimilars/follow-on-biologics Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Biosimilars/follow-on-biologics Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Biosimilars/follow-on-biologics Market Share by Region (2016-2027)
Figure 45. China Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Biosimilars/follow-on-biologics Market Share by Type (2016-2027)
Figure 53. Latin America Biosimilars/follow-on-biologics Market Share by Application (2016-2027)
Figure 54. Latin America Biosimilars/follow-on-biologics Market Share by Country (2016-2027)
Figure 55. Mexico Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Biosimilars/follow-on-biologics Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Biosimilars/follow-on-biologics Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Biosimilars/follow-on-biologics Market Share by Country (2016-2027)
Figure 61. Turkey Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Biosimilars/follow-on-biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Novartis (Sandoz) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2016-2021)
Figure 65. Synthon Pharmaceuticals Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2016-2021)
Figure 66. Teva Pharmaceutical Industries Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2016-2021)
Figure 67. LG Life Sciences Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2016-2021)
Figure 68. Celltrion Biocon Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2016-2021)
Figure 69. Hospira Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2016-2021)
Figure 70. Merck Serono (Merck) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2016-2021)
Figure 71. Biogen idec Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2016-2021)
Figure 72. Genentech (Roche) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

---